Caffeine Citrate in Preterm Infants at Risk of Apnea in Zambia

NCT06518603 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

340

Enrollment

OTHER

Sponsor class

Conditions

Premature Infant Disease
Apnea of Prematurity
Development, Infant

Interventions

DRUG: Caffeine citrate 20mg/kg/day
DRUG: Placebo-Sterile water 1ml/kg/day

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]